Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
EGFR bi-armed autologous activated T cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Barbara Ann Karmanos Cancer Institute
Drug class:
CD3 inhibitor
Related drugs:
‹
MGD007 (0)
muromonab-CD3 (0)
VG712 (0)
ertumaxomab (0)
SLAMF7 FPBMC (0)
anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)
MGD007 (0)
muromonab-CD3 (0)
VG712 (0)
ertumaxomab (0)
SLAMF7 FPBMC (0)
anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.